|
1
|
Jones JA, Avritscher EB, Cooksley CD,
Michelet M, Bekele BN and Elting LS: Epidemiology of
treatment-associated mucosal injury after treatment with newer
regimens for lymphoma, breast, lung, or colorectal cancer. Support
Care Cancer. 14:505–515. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elting LS, Cooksley C, Chambers M, Cantor
SB, Manzullo E and Rubenstein EB: The burdens of cancer therapy.
Clinical and economic outcomes of chemotherapy-induced mucositis.
Cancer. 98:1531–1539. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sonis ST, Elting LS, Keefe D, Peterson DE,
Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly
JP and Rubenstein EB; Mucositis Study Section of the Multinational
Association for Supportive Care in Cancer; International Society
for Oral Oncology: Perspectives on cancer therapy-induced mucosal
injury: Pathogenesis, measurement, epidemiology, and consequences
for patients. Cancer. 100(Suppl 9): 1995–2025. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rubenstein EB, Peterson DE, Schubert M,
Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C and
Sonis ST; Mucositis Study Section of the Multinational Association
for Supportive Care in Cancer; International Society for Oral
Oncology: Clinical practice guidelines for the prevention and
treatment of cancer therapy-induced oral and gastrointestinal
mucositis. Cancer. 100(Suppl 9): 2026–2046. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nishimura N, Nakano K, Ueda K, Kodaira M,
Yamada S, Mishima Y, Yokoyama M, Terui Y, Takahashi S and Hatake K:
Prospective evaluation of incidence and severity of oral mucositis
induced by conventional chemotherapy in solid tumors and malignant
lymphomas. Support Care Cancer. 20:2053–2059. 2012. View Article : Google Scholar
|
|
6
|
Hayashi K, Ando N, Watanabe H, Ide H,
Nagai K, Aoyama N, Takiyama W, Ishida K, Isono K, Makuuchi H, et
al: Phase II evaluation of protracted infusion of cisplatin and
5-fluorouracil in advanced squamous cell carcinoma of the
esophagus: A Japan Esophageal Oncology Group (JEOG) Trial
(JCOG9407). Jpn J Clin Oncol. 31:419–423. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tanaka Y, Takahashi T, Yamaguchi K, Osada
S, Shimokawa T and Yoshida K: Elemental diet plus glutamine for the
prevention of mucositis in esophageal cancer patients receiving
chemotherapy: a feasibility study. Support Care Cancer. 24:933–941.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bozzetti F and Group SW: Screening the
nutritional status in oncology: a preliminary report on 1,000
outpatients. Support Care Cancer. 17:279–284. 2009. View Article : Google Scholar
|
|
9
|
Norman K, Stobäus N, Zocher D,
Bosy-Westphal A, Szramek A, Scheufele R, Smoliner C and Pirlich M:
Cutoff percentiles of bioelectrical phase angle predict
functionality, quality of life, and mortality in patients with
cancer. Am J Clin Nutr. 92:612–619. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martin L, Birdsell L, Macdonald N, Reiman
T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB and
Baracos VE: Cancer cachexia in the age of obesity: Skeletal muscle
depletion is a powerful prognostic factor, independent of body mass
index. J Clin Oncol. 31:1539–1547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sabel MS, Lee J, Cai S, Englesbe MJ,
Holcombe S and Wang S: Sarcopenia as a prognostic factor among
patients with stage III melanoma. Ann Surg Oncol. 18:3579–3585.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Antoun S, Lanoy E, Iacovelli R,
Albiges-Sauvin L, Loriot Y, Merad-Taoufik M, Fizazi K, di Palma M,
Baracos VE and Escudier B: Skeletal muscle density predicts
prognosis in patients with metastatic renal cell carcinoma treated
with targeted therapies. Cancer. 119:3377–3384. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iritani S, Imai K, Takai K, Hanai T, Ideta
T, Miyazaki T, Suetsugu A, Shiraki M, Shimizu M and Moriwaki H:
Skeletal muscle depletion is an independent prognostic factor for
hepatocellular carcinoma. J Gastroenterol. 50:323–332. 2015.
View Article : Google Scholar
|
|
14
|
Barret M, Antoun S, Dalban C, Malka D,
Mansourbakht T, Zaanan A, Latko E and Taieb J: Sarcopenia is linked
to treatment toxicity in patients with metastatic colorectal
cancer. Nutr Cancer. 66:583–589. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tan BH, Birdsell LA, Martin L, Baracos VE
and Fearon KC: Sarcopenia in an overweight or obese patient is an
adverse prognostic factor in pancreatic cancer. Clin Cancer Res.
15:6973–6979. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prado CM, Baracos VE, McCargar LJ, Reiman
T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E and
Sawyer MB: Sarcopenia as a determinant of chemotherapy toxicity and
time to tumor progression in metastatic breast cancer patients
receiving capecitabine treatment. Clin Cancer Res. 15:2920–2926.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prado CM, Lieffers JR, McCargar LJ, Reiman
T, Sawyer MB, Martin L and Baracos VE: Prevalence and clinical
implications of sarcopenic obesity in patients with solid tumours
of the respiratory and gastrointestinal tracts: A population-based
study. Lancet Oncol. 9:629–635. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Awad S, Tan BH, Cui H, Bhalla A, Fearon
KC, Parsons SL, Catton JA and Lobo DN: Marked changes in body
composition following neoadjuvant chemotherapy for oesophagogastric
cancer. Clin Nutr. 31:74–77. 2012. View Article : Google Scholar
|
|
19
|
Baracos VE, Reiman T, Mourtzakis M,
Gioulbasanis I and Antoun S: Body composition in patients with
non-small cell lung cancer: A contemporary view of cancer cachexia
with the use of computed tomography image analysis. Am J Clin Nutr.
91:1133S–1137S. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bower MR and Martin RC II: Nutritional
management during neoadjuvant therapy for esophageal cancer. J Surg
Oncol. 100:82–87. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peterson DE, Jones JB and Petit RG II:
Randomized, placebo-controlled trial of Saforis for prevention and
treatment of oral mucositis in breast cancer patients receiving
anthracycline-based chemotherapy. Cancer. 109:322–331. 2007.
View Article : Google Scholar
|
|
22
|
Choi K, Lee SS, Oh SJ, Lim SY, Lim SY,
Jeon WK, Oh TY and Kim JW: The effect of oral glutamine on
5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by
intestinal permeability test. Clin Nutr. 26:57–62. 2007. View Article : Google Scholar
|
|
23
|
Tsujimoto T, Yamamoto Y, Wasa M, Takenaka
Y, Nakahara S, Takagi T, Tsugane M, Hayashi N, Maeda K, Inohara H,
et al: L-glutamine decreases the severity of mucositis induced by
chemoradiotherapy in patients with locally advanced head and neck
cancer: A double-blind, randomized, placebo-controlled trial. Oncol
Rep. 33:33–39. 2015.
|
|
24
|
Wolfe RR: Regulation of muscle protein by
amino acids. J Nutr. 132:3219S–3224S. 2002.PubMed/NCBI
|
|
25
|
de Campos-Ferraz PL, Andrade I, das Neves
W, Hangai I, Alves CR and Lancha AH Jr: An overview of amines as
nutritional supplements to counteract cancer cachexia. J Cachexia
Sarcopenia Muscle. 5:105–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Malavolti M, Mussi C, Poli M, Fantuzzi AL,
Salvioli G, Battistini N and Bedogni G: Cross-calibration of
eight-polar bioelectrical impedance analysis versus dual-energy
X-ray absorptiometry for the assessment of total and appendicular
body composition in healthy subjects aged 21–82 years. Ann Hum
Biol. 30:380–391. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen LK, Liu LK, Woo J, Assantachai P,
Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, et al:
Sarcopenia in Asia: Consensus report of the Asian Working Group for
Sarcopenia. J Am Med Dir Assoc. 15:95–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fukui T, Itoh Y, Orihara M, Yoshizawa K,
Takeda H, Kawada S and Yoshioka T: Elental prevented and reduced
oral mucositis during chemotherapy in patients esophageal cancer.
Gan To Kagaku Ryoho. 38:2597–2601. 2011.In Japanese. PubMed/NCBI
|
|
29
|
Ogata Y, Takeuchi M, Ishibashi N, Kibe S,
Takahashi K, Uchida S, Murakami N, Yahara T and Shirouzu K:
Efficacy of Elental on prevention for chemotherapy-induced oral
mucositis in colorectal cancer patients. Gan To Kagaku Ryoho.
39:583–587. 2012.In Japanese. PubMed/NCBI
|
|
30
|
Ogata Y, Ishibashi N, Yamaguchi K, Uchida
S, Kamei H, Nakayama G, Hirakawa H, Tanigawa M and Akagi Y:
Preventive effects of amino-acid-rich elemental diet Elental on
chemotherapy-induced oral mucositis in patients with colorectal
cancer: a prospective pilot study. Support Care Cancer. 24:783–789.
2015. View Article : Google Scholar
|
|
31
|
Tebbutt NC, Cummins MM, Sourjina T,
Strickland A, Van Hazel G, Ganju V, Gibbs D, Stockler M, Gebski V
and Zalcberg J; Australasian Gastro-Intestinal Trials Group:
Randomised, non-comparative phase II study of weekly docetaxel with
cisplatin and 5-fluorouracil or with capecitabine in
oesophagogastric cancer: The AGITG ATTAX trial. Br J Cancer.
102:475–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Anandavadivelan P, Brismar TB, Nilsson M,
Johar AM and Martin L: Sarcopenic obesity: A probable risk factor
for dose limiting toxicity during neo-adjuvant chemotherapy in
oesophageal cancer patients. Clin Nutr. 35:724–730. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tan BH, Brammer K, Randhawa N, Welch NT,
Parsons SL, James EJ and Catton JA: Sarcopenia is associated with
toxicity in patients undergoing neo-adjuvant chemotherapy for
oesophagogastric cancer. Eur J Surg Oncol. 41:333–338. 2015.
View Article : Google Scholar
|
|
34
|
Yip C, Goh V, Davies A, Gossage J,
Mitchell-Hay R, Hynes O, Maisey N, Ross P, Gaya A, Landau DB, et
al: Assessment of sarcopenia and changes in body composition after
neoadjuvant chemotherapy and associations with clinical outcomes in
oesophageal cancer. Eur Radiol. 24:998–1005. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Harada K, Ida S, Baba Y, Ishimoto T,
Kosumi K, Tokunaga R, Izumi D, Ohuchi M, Nakamura K, Kiyozumi Y, et
al: Prognostic and clinical impact of sarcopenia in esophageal
squamous cell carcinoma. Dis Esophagus. Jun 30–2015.Epub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
van Vledder MG, Levolger S, Ayez N,
Verhoef C, Tran TC and Ijzermans JN: Body composition and outcome
in patients undergoing resection of colorectal liver metastases. Br
J Surg. 99:550–557. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Larrea J, Vega S, Martínez T, Torrent JM,
Vega V and Núñez V: The nutritional status and immunological
situation of cancer patients. Nutr Hosp. 7:178–184. 1992.In
Spanish. PubMed/NCBI
|
|
38
|
Daly JM, Massar E, Giacco G, Frazier OH,
Mountain CF, Dudrick SJ and Copeland EM III: Parenteral nutrition
in esophageal cancer patients. Ann Surg. 196:203–208. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takesue T, Takeuchi H, Ogura M, Fukuda K,
Nakamura R, Takahashi T, Wada N, Kawakubo H and Kitagawa Y: A
prospective randomized trial of enteral nutrition after
thoracoscopic esophagectomy for esophageal cancer. Ann Surg Oncol.
22(Suppl 3): S802–S809. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Paddon-Jones D, Sheffield-Moore M,
Katsanos CS, Zhang XJ and Wolfe RR: Differential stimulation of
muscle protein synthesis in elderly humans following isocaloric
ingestion of amino acids or whey protein. Exp Gerontol. 41:215–219.
2006. View Article : Google Scholar
|
|
41
|
Katsanos CS, Kobayashi H, Sheffield-Moore
M, Aarsland A and Wolfe RR: A high proportion of leucine is
required for optimal stimulation of the rate of muscle protein
synthesis by essential amino acids in the elderly. Am J Physiol
Endocrinol Metab. 291:E381–E387. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Garlick PJ: The role of leucine in the
regulation of protein metabolism. J Nutr. 135(Suppl): 1553S–1556S.
2005.PubMed/NCBI
|
|
43
|
Miyoshi J, Miyamoto H, Goji T, Taniguchi
T, Tomonari T, Sogabe M, Kimura T, Kitamura S, Okamoto K, Fujino Y,
et al: Serum diamine oxidase activity as a predictor of
gastrointestinal toxicity and malnutrition due to anticancer drugs.
J Gastroenterol Hepatol. 30:1582–1590. 2015. View Article : Google Scholar : PubMed/NCBI
|
